What is the price of China Chemical & Pharmaceutical Co., Ltd. (1701)

The price of China Chemical & Pharmaceutical Co., Ltd. (1701) is $0.65890555

What is the market cap of China Chemical & Pharmaceutical Co., Ltd. (1701)

The market cap of China Chemical & Pharmaceutical Co., Ltd. (1701) is $194.28M

China Chemical & Pharmaceutical Co., Ltd. (1701) Price History

China Chemical & Pharmaceutical Co., Ltd. (CCP), established in Taipei, Taiwan, in 1952, is a prominent player in the pharmaceutical sector. The company specializes in the research, development, manufacturing, and distribution of generic pharmaceutical and healthcare products, serving both human and animal health markets. Its extensive human pharmaceutical portfolio encompasses a wide array of therapeutic areas. Key offerings include medications for cardiovascular health (such as treatments for heart conditions, cholesterol management, and peripheral circulation disorders), metabolic conditions (including diabetes, weight management, and corticosteroid therapies), and infectious diseases (like antibiotics, antifungals, and antivirals). CCP also provides a range of nutritional supplements, from vitamins and hepatic support agents to electrolyte and caloric preparations. Other significant categories cover pain and inflammation relief (antipyretics, analgesics, anti-inflammatories), digestive system remedies (gastrointestinal drugs, gut health enhancers, antispasmodics), and respiratory treatments (antitussives, antihistamines, and asthma medications). Furthermore, the company produces drugs addressing urological issues (specifically for benign prostatic hyperplasia), central nervous system disorders (hypnotics, mood stabilizers, and antidepressants), and critical areas like hematology and oncology, alongside other general preparations and sexual well-being products. Beyond prescription medications, CCP's non-prescription (OTC) division offers popular consumer health products, such as vitamins, topical skincare items, cold and cough remedies, anti-inflammatory pain relievers, and digestive aids. The company additionally supplies antibacterial and disinfectant solutions. In the animal health sector, CCP manufactures veterinary pharmaceuticals catering to livestock (pigs and cattle), poultry, and companion animals, alongside various feed supplements. Rounding out its operations, China Chemical & Pharmaceutical Co., Ltd. offers contract manufacturing services to other industry players.

Year	Performance
2024	-17.17%
2023	-12.95%
2022	11.73%
2021	-0.40%
2020	30.07%
2019	5.84%
2018	-3.87%
2017	9.75%
2016	-5.81%
2015	-6.14%
2014	-17.61%
2013	11.78%
2012	25.40%
2011	-45.03%
2010	36.43%
2009	94.15%
2008	-23.29%
2007	40.92%
2006	6.08%
2005	-6.49%
2004	53.93%
2003	32.68%
2002	5.40%
2001	-4.44%
2000	0.00%

Year

Performance

2024

-17.17%

2023

-12.95%

2022

11.73%

2021

-0.40%

2020

30.07%

2019

5.84%

2018

-3.87%

2017

9.75%

2016

-5.81%

2015

-6.14%

2014

-17.61%

2013

11.78%

2012

25.40%

2011

-45.03%

2010

36.43%

2009

94.15%

2008

-23.29%

2007

40.92%

2006

6.08%

2005

-6.49%

2004

53.93%

2003

32.68%

2002

5.40%

2001

-4.44%

2000

0.00%

Company	Stock price	Change 1y%	Country
MERCK Kommanditgesellschaft auf Aktien MER.SW	$171.67	-	DE
Merck KGaA MRK.DE	$165.17	29.24%	DE
Takeda Pharmaceutical Company Limited 4502.T	$38.45	26.55%	JP
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	$21.17	18.10%	IN
Galderma Group AG GALD.SW	$214.98	24.44%	CH

Company

Stock price

Change 1y%

Country